These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 521216)

  • 1. Formation and synthesis of 3'-t-butyltyrosine.
    Lundt BF; Johansen NL; Markussen J
    Int J Pept Protein Res; 1979 Oct; 14(4):344-6. PubMed ID: 521216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient solid phase synthesis of mixed Thr(P)-, Ser(P)- and Tyr(P)-containing phosphopeptides by "global" "phosphite-triester" phosphorylation.
    Perich JW
    Int J Pept Protein Res; 1992 Aug; 40(2):134-40. PubMed ID: 1280250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fmoc/solid-phase synthesis of Tyr(P)-containing peptides through t-butyl phosphate protection.
    Perich JW; Reynolds EC
    Int J Pept Protein Res; 1991 Jun; 37(6):572-5. PubMed ID: 1717394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of o,o'-dityrosine, o-nitrotyrosine, and o-tyrosine in cat urine samples by LC/ electrospray ionization-MS/MS using isotope dilution.
    Marvin LF; Delatour T; Tavazzi I; Fay LB; Cupp C; Guy PA
    Anal Chem; 2003 Jan; 75(2):261-7. PubMed ID: 12553760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An efficient synthesis of N-tert-butoxycarbonyl-O-cyclohexyl-L-tyrosine.
    Nishiyama Y; Ishizuka S; Shikama S; Kurita K
    Chem Pharm Bull (Tokyo); 2001 Feb; 49(2):233-5. PubMed ID: 11217115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Removal of t-butyl and t-butoxycarbonyl protecting groups with trifluoroacetic acid. Mechanisms, biproduct formation and evaluation of scavengers.
    Lundt BF; Johansen NL; Vølund A; Markussen J
    Int J Pept Protein Res; 1978 Nov; 12(5):258-68. PubMed ID: 744685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the mode of antigen presentation required for triggering of T cell proliferation by using various azobenzenearsonate-tyrosine derivatives.
    Tadakuma T; Yasuda T; Tamura A; Saito S; Tsumita T; Saito K
    J Immunol; 1985 Jan; 134(1):122-8. PubMed ID: 3871097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural character and energetics of tyrosyl radical formation by electron/proton transfers of a covalently linked histidine-tyrosine: a model for cytochrome C oxidase.
    Bu Y; Cukier RI
    J Phys Chem B; 2005 Nov; 109(46):22013-26. PubMed ID: 16853859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Facile solid-phase synthesis of sulfated tyrosine-containing peptides: total synthesis of human big gastrin-II and cholecystokinin (CCK)-39.
    Kitagawa K; Aida C; Fujiwara H; Yagami T; Futaki S; Kogire M; Ida J; Inoue K
    J Org Chem; 2001 Jan; 66(1):1-10. PubMed ID: 11429884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of plasmin-selective inhibitors and studies of their structure-activity relationship.
    Okada Y; Matsumoto Y; Tsuda Y; Tada M; Wanaka K; Hijikata-Okunomiya A; Okamoto S
    Chem Pharm Bull (Tokyo); 2000 Feb; 48(2):184-93. PubMed ID: 10705502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination and occurrence of tyrosine O-sulfate in proteins.
    Huttner WB
    Methods Enzymol; 1984; 107():200-23. PubMed ID: 6390090
    [No Abstract]   [Full Text] [Related]  

  • 12. [Theoretical conformational analysis of noinvalent carboxypeptidase A complexes with inhibitors and substrates].
    Lipkind GM; Paslen VV
    Mol Biol (Mosk); 1980; 14(5):1142-50. PubMed ID: 7421820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exposure of aromatic residues of Streptomyces subtilisin inhibitor. A photo-CIDNP study.
    Akasaka K; Fujii S; Kaptein R
    J Biochem; 1981 Jun; 89(6):1945-9. PubMed ID: 6270074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The preparation and pharmacological properties of 3-acetyltyrosine and 3-acetyltyramine.
    Florvall L; Ross SB; Ogren SO; Stjernström NE
    Acta Pharm Suec; 1978; 15(1):13-22. PubMed ID: 645365
    [No Abstract]   [Full Text] [Related]  

  • 15. The EPR spectrum of tyrosine Z* and its decay kinetics in O2-evolving photosystem II preparations.
    Ioannidis N; Zahariou G; Petrouleas V
    Biochemistry; 2008 Jun; 47(24):6292-300. PubMed ID: 18494501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, spectroscopic and structural elucidation of tyrosinamide hydrogensquarate monohydrate.
    Kolev TM; Koleva BB; Spiteller M; Sheldrick WS; Mayer-Figge H
    Amino Acids; 2009 Feb; 36(2):195-201. PubMed ID: 18317871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the catalytic actions of poly-alpha-amino acids. I. Hydrolysis of p-nitrophenyl acetate by an interaction field between hydroxyl and carboxyl groups of copoly(L-Tyr, L-Glu) or copoly(L-Tyr, L-Asp).
    Noguchi J; Yamamoto H
    J Biochem; 1969 Jan; 65(1):123-32. PubMed ID: 5771703
    [No Abstract]   [Full Text] [Related]  

  • 18. Side-chain-anchored N(alpha)-Fmoc-Tyr-OPfp for bidirectional solid-phase synthesis.
    Olsen CA; Jørgensen MR; Hansen SH; Witt M; Jaroszewski JW; Franzyk H
    Org Lett; 2005 Apr; 7(9):1703-6. PubMed ID: 15844885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of a novel nonphosphorylated pentapeptide motif displaying high affinity for Grb2-SH2 domain by the utilization of 3'-substituted tyrosine derivatives.
    Song YL; Peach ML; Roller PP; Qiu S; Wang S; Long YQ
    J Med Chem; 2006 Mar; 49(5):1585-96. PubMed ID: 16509576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel general route for the synthesis of C-glycosyl tyrosine analogues.
    Brenna E; Fuganti C; Grasselli P; Serra S; Zamboti S
    Chemistry; 2002 Apr; 8(8):1872-8. PubMed ID: 12007097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.